Incidence and Predictors of Multiple Fractures Despite High Adherence to Oral Bisphosphonates: A Binational Population-Based Cohort Study-Reference-Cited by-同舟云学术

Incidence and Predictors of Multiple Fractures Despite High Adherence to Oral Bisphosphonates: A Binational Population-Based Cohort Study

Published:2016-01 Issue:1 Volume:31 Page:234-244
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Hawley Samuel¹,Javaid M Kassim¹²,Rubin Katrine H³,Judge Andrew¹²,Arden Nigel K¹²,Vestergaard Peter⁴,Eastell Richard⁵,Diez-Perez Adolfo⁶,Cooper Cyrus¹²,Abrahamsen Bo³⁷,Prieto-Alhambra Daniel¹²⁶⁸

Affiliation:

1. Oxford National Institute for Health Research (NIHR) Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences; University of Oxford; Oxford UK

2. Medical Research Council (MRC) Lifecourse Epidemiology Unit; University of Southampton; Southampton UK

3. Odense Patient Data Explorative Network (OPEN), Institute of Clinical Research; University of Southern Denmark; Odense Denmark

4. Departments of Clinical Medicine and Endocrinology; Aalborg University Hospital; Aalborg Denmark

5. Department of Human Metabolism; University of Sheffield; Sheffield UK

6. Hospital del Mar Medical Research Institute (IMIM), Universitat Autònoma de Barcelona and Red Temática de Investigación Cooperativa en Envejecimiento y Fragilidad (RETICEF); Instituto de Salud Carlos III; Barcelona Spain

7. Research Centre for Ageing and Osteoporosis; Glostrup Hospital; Glostrup Denmark

8. Grup de Recerca en Malalties Prevalents de l'Aparell Locomotor (GREMPAL) Research Group, Institut d'Investigació en Atenció Primària (IDIAP) Jordi Gol Primary Care Research Institute; Universitat Autònoma de Barcelona; Barcelona Spain

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbmr.2595/fullpdf

Reference36 articles.

1. European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). European guidance for the diagnosis and management of osteoporosis in postmenopausal women;Kanis;Osteoporos Int,2008

2. HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis;Black;N Engl J Med,2007

3. Fracture Intervention Trial. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group;Black;J Clin Endocrinol Metab,2000

4. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group;Harris;JAMA,1999

5. Risk factors for prediction of inadequate response to antiresorptives;Díez-Pérez;J Bone Miner Res,2012

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteoporosis Management in Patients with Hip Fracture post Fall;International Journal of Men's Social and Community Health;2024-08-29

2. Osteoporosis Management in Patients with Hip Fracture post Fall;International Journal of Men's Social and Community Health;2024-04-22

3. Bisphosphonate alternative regimens for the prevention of osteoporotic fragility fractures: BLAST-OFF, a mixed-methods study;HEALTH TECHNOL ASSES;2024

4. Current approaches to secondary prevention after hip fracture in England and Wales — an analysis of trends between 2016 and 2020 using the National Hip Fracture Database (NHFD);Archives of Osteoporosis;2023-07-10

5. Potential of Health Insurance Claims Data to Predict Fractures in Older Adults: A Prospective Cohort Study;Clinical Epidemiology;2022-10